1. Inicio
  2. Proyectos y Estudios
  3. A POST-AUTHORISATION SAFETY STUDY PATIENT REGISTRY OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA BEING TREATED WITH THE MONOCLONAL ANTIBODY DINUTUXIMAB BETA.

A POST-AUTHORISATION SAFETY STUDY PATIENT REGISTRY OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA BEING TREATED WITH THE MONOCLONAL ANTIBODY DINUTUXIMAB BETA.

Datos básicos

ESTUDIO OBSERVACIONAL EUS-DIN-2019-01 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2019

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

EUSA PHARMA (UK) LTD

Cita

Compartir